AIM
PRAH

Alambic Investment Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Alambic Investment Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,500
Closed -$228K – 708
2017
Q1 		$228K Buy
+3,500
New +$206K 0.03% 554

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Alambic Investment Management's PRAH Position: Q2 2017 in Review

Alambic Investment Management sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2017, closing a stake of 3,500 shares — an estimated $228K sold.

Alambic Investment Management first reported a position in PRAH in Q1 2017 and held it in 1 quarter. The position peaked at $228K in Q1 2017. 236 funds tracked by Wall St. Rank hold PRAH as of Q2 2017.

  • Alambic Investment Management reported no remaining PRA Health Sciences, Inc. position as of Q2 2017 after selling out during the quarter.
  • Alambic Investment Management sold 3,500 PRA Health Sciences, Inc. shares in Q2 2017, an estimated $228K.
  • Alambic Investment Management first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 1 quarter.
  • Alambic Investment Management's PRA Health Sciences, Inc. position peaked at $228K in Q1 2017.
  • 236 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2017.

Based on Alambic Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.